DPP-4 inhibitors get spotlight at ADA meeting
This is a discussion on DPP-4 inhibitors get spotlight at ADA meeting within the Biotechnology News forum, part of the Industry News and Updates category; Researchers are unveiling positive data at the American Diabetes Association's meeting for new DPP-4 inhibitors for diabetes. Takeda ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-10-2008, 08:52 AM
|
|||
|
|||
DPP-4 inhibitors get spotlight at ADA meeting
Researchers are unveiling positive data at the American Diabetes Association's meeting for new DPP-4 inhibitors for diabetes. Takeda is the latest, demonstrating that its alogliptin can control blood Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cholinesterase inhibitors in brain damage | participant3 | Managed Care Issues for Oral Drugs | 1 | 05-08-2008 02:15 PM |
© 2008 DrugManagementForum™ powered by |
 |